This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, San Francisco


Maveron was established in 1998, and is a well known VC. The VC's location is in North America, United States. The main office of this VC is situated in San Francisco.

The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 1 other location. Among the most popular investment industries for the fund are Health Care, Retail. However, the fund’s focus is not limited to this, since there are 29 more areas of investment. The fund has no specific requirements for the number of founders in a start-up. When a start-up has 5+ founders, the probability of closing the deal is low. The average start-up age at the time of investment by this fund is 2-3. Groupon, zulily, Zume Pizza are amongst the various portfolio companies of this fund.

The fund usually invests in rounds together with 5-6 others. Along with Maveron, start-ups are often financed by Oak Investment Partners, Slow Ventures, Madrona Venture Group as well as 121 other investors. The fund often co-invests with Trilogy Equity Partners, Greycroft, Founders' Co-op, overall with 179 funds from our list. In subsequent rounds, the fund is usually supported by True Ventures, Lerer Hippeau, Greycroft, out of 133 investors from our database.

The fund was established by Dan Levitan, Howard Schultz. We also identified another 9 core personnel in our database.

The fund generally invests in 7-12 deals every year. The most exits for the fund occurred in 2013. In comparison with other funds, Maveron makes 12 percentage points less than the average number of lead investments. The fund's activity peaked in 2017. In addition, the fund was active in 2019. The most common rounds for this fund are in the range of 5 - 10 millions dollars. The fund performance shows that this VC achieves 7 percentage points more exits in comparison to other VCs. When Maveron invests, the average start-up valuation is 10-50 millions dollars.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first_initial last, first last, last, last first_initial, first

Group Appearance [how often fund is operating separately from groups with shared interest]

97.3% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

30.2% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

4.6 years

Decision Makers / Strategy
Similarity Index [see explanation at]

0.11 out of 1

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.25 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Number of Decacorns [amount of portfolio companies, which were valuated at more then $10B]


Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]


Funds Investing in Following

True Ventures, Lerer Hippeau, Greycroft

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: